CEL-SCI Corp has a consensus price target of $13 based on the ratings of 2 analysts. The high is $16 issued by EF Hutton on December 29, 2022. The low is $10 issued by EF Hutton on July 12, 2023. The 3 most-recent analyst ratings were released by EF Hutton on July 12, 2023, March 9, 2023, and February 17, 2023, respectively. With an average price target of $10 between EF Hutton, there's an implied 1270.05% upside for CEL-SCI Corp from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for CEL-SCI (AMEX:CVM) was reported by EF Hutton on July 12, 2023. The analyst firm set a price target for $10.00 expecting CVM to rise to within 12 months (a possible 1270.05% upside). 0 analyst firms have reported ratings in the last year.
The latest analyst rating for CEL-SCI (AMEX:CVM) was provided by EF Hutton, and CEL-SCI reiterated their buy rating.
There is no last upgrade for CEL-SCI
There is no last downgrade for CEL-SCI.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CEL-SCI, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CEL-SCI was filed on July 12, 2023 so you should expect the next rating to be made available sometime around July 12, 2024.
While ratings are subjective and will change, the latest CEL-SCI (CVM) rating was a reiterated with a price target of $0.00 to $10.00. The current price CEL-SCI (CVM) is trading at is $0.73, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.